3 completed, 1 recruiting, 1 terminated, 1 unknown. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 3, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Myocet: new trials by email Literature Review of Myocet trials Research Report on Myocet
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7) Nemvaleukin and Pembrolizumab Combination, Pembrolizumab, Nemvaleukin - Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Terminated | Mural Oncology, Inc | 456 | 2022-01-10 | 2025-08-28 |
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017 Blinatumomab, Bortezomib, Cyclophosphamide - Acute Lymphoblastic Leukemia, Pediatric | Phase 3 | Recruiting | Martin Schrappe | 5000 | 2018-07-15 | 2025-04-06 |
| A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) non-pegylated liposomal doxorubicin, Carboplatin, Paclitaxel - Tubular Breast Cancer Stage II, Tubular Breast Cancer Stage III | Phase 3 | Completed | GBG Forschungs GmbH | 961 | 2014-12-01 | 2017-07-13 |
| A Prospective, Multicenter, Open-label 12 Week Neoadjuvant Phase II Trial Optimizing Taxane Therapy in Elderly Patients With Low Response Myocet, Cyclophosphamide, Paclitaxel - Early Primary Breast Cancer | Phase 3 | Completed | Women's Cancer Study Group GmbH | 80 | 2014-07-01 | 2025-02-27 |
| Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer Carboplatin, background treatment - Tubular Breast Cancer Stage II, Mucinous Breast Cancer Stage II | Phase 2 / Phase 3 | Completed | GBG Forschungs GmbH | 595 | 2011-08-01 | 2016-02-15 |
| Trial of Myocet in Metastatic Breast Cancer Myocet - Breast Cancer | Phase 3 | Unknown | Sopherion Therapeutics | 363 | 2006-01-01 | 2009-03-31 |
Breast Neoplasms (2) · Carcinoma, Ductal, Breast (2) · Inflammatory Breast Neoplasms (2) · Fallopian Tube Neoplasms (1) · Ovarian Neoplasms (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
GBG Forschungs GmbH (2) · Martin Schrappe (1) · Mural Oncology, Inc (1) · Sopherion Therapeutics (1) · Women's Cancer Study Group GmbH (1)
Germany (6) · Italy (3) · Australia (2) · Austria (2) · Canada (2) · Czechia (2) · Spain (2) · United Kingdom (2) · United States (2) · Argentina (1) · Belgium (1) · France (1) · India (1) · Israel (1) · Poland (1)
Andreas Schneeweiss, MD, Prof. (1) · Gunter von Minckwitz, MD, Prof (1) · Jose Baselga, M.D. (1) · Martin Schrappe, MD (1) · Nadia Harbeck, Prof. Dr. (1) · Ulrike Nitz, Prof. Dr. (1)
PMID 24401928, PMID 24794243, PMID 25199759, PMID 25534375, PMID 28715532, PMID 30528802, PMID 32163106, PMID 33191846, PMID 34252375, PMID 34801353, PMID 35129146, PMID 37334673, PMID 38841802, PMID 41671463, PMID 42748428